Le Coulant P, Leuret JP, Texier L, Kermarec J, Maleville J, Aubertin J. A case of systemic amyloidosis with plasma cell infiltration and secondary epithelioma of the liver. Presse Med. 1893;68:820–822.

Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci. 2017;186(1):57–62. https://doi.org/10.1007/s11845-016-1464-0.

Article  CAS  PubMed  Google Scholar 

Abbott M, Ustoyev Y. Cancer and the Immune System: The History and Background of Immunotherapy. Semin Oncol Nurs. 2019;35(5): 150923. https://doi.org/10.1016/j.soncn.2019.08.002.

Article  PubMed  Google Scholar 

Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: From tumor initiation to metastatic progression. Genes Dev. 2018;32(19–20):1267–84. https://doi.org/10.1101/GAD.314617.118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loose D, Van De Wiele C. The immune system and cancer. Cancer Biother Radiopharm. 2009;24(3):369–76. https://doi.org/10.1089/cbr.2008.0593.

Article  CAS  PubMed  Google Scholar 

Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345–59. https://doi.org/10.1038/s41568-021-00347-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakowska J, et al. Autoimmunity and Cancer—Two Sides of the Same Coin. Front Immunol. 2022;13(May):1–22. https://doi.org/10.3389/fimmu.2022.793234.

Article  CAS  Google Scholar 

De Sousa Linhares A, Leitner J, Grabmeier-Pfistershammer K, Steinberger P. Not All Immune Checkpoints Are Created Equal. Front Immunol. 2018;9:1–15, 2018. https://doi.org/10.3389/fimmu.2018.01909.

Ceccarelli F, Agmon-Levin N, Perricone C. Genetic Factors of Autoimmune Diseases 2017. J Immunol Res. 2017. Hindawi. https://doi.org/10.1155/2017/2789242.

Schmidt J et al. Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors. Nat Commun. 2023;14(1). https://doi.org/10.1038/s41467-023-38946-z.

Hu X, et al. Cancer Risk in Hashimoto’s Thyroiditis: a Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2022;13(July):1–10. https://doi.org/10.3389/fendo.2022.937871.

Article  Google Scholar 

Quaglino P, et al. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: Results from a single-institution hospital-based observational cohort study. Ann Oncol. 2010;21(2):409–14. https://doi.org/10.1093/annonc/mdp325.

Article  CAS  PubMed  Google Scholar 

Boi F, Pani F, Mariotti S. Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies. European Thyroid Journal. 2017;6(4):178–86. https://doi.org/10.1159/000468928.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hua C, et al. Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab. JAMA dermatology. 2016;152(1):45–51. https://doi.org/10.1001/jamadermatol.2015.2707.

Article  PubMed  Google Scholar 

Hu X, Chen Y, Shen Y, Tian R, Sheng Y, Que H. Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A systematic review and meta-analysis. Front Public Heal. 2022;10. https://doi.org/10.3389/fpubh.2022.1020709.

Ragusa F, et al. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6): 101367. https://doi.org/10.1016/j.beem.2019.101367.

Article  PubMed  Google Scholar 

Diab N et al. Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community. Sci Rep. 2019;9(1):13156. https://doi.org/10.1038/s41598-019-49540-z.

Hollowell JG, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99. https://doi.org/10.1210/jcem.87.2.8182.

Article  CAS  PubMed  Google Scholar 

Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923–931. https://doi.org/10.1210/jc.2013-2409.

Mendes D, Alves C, Silverio N, Marques FB. Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis. Eur Thyroid J. 2019;8(3):130–43. https://doi.org/10.1159/000499751.

Article  PubMed  PubMed Central  Google Scholar 

Ralli M, et al. Hashimoto’s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10): 102649. https://doi.org/10.1016/j.autrev.2020.102649.

Article  CAS  PubMed  Google Scholar 

Bery AI, Shepherd HM, Li W, Krupnick AS, Gelman AE, Kreisel D. Role of tertiary lymphoid organs in the regulation of immune responses in the periphery. Cell Mol Life Sci. 2022;79(7):1–18. https://doi.org/10.1007/s00018-022-04388-x.

Article  CAS  Google Scholar 

Ferrari SM, et al. Chemokines in thyroid autoimmunity. Best Pract Res Clin Endocrinol Metab. 2023;37(2):101773. https://doi.org/10.1016/j.beem.2023.101773.

Álvarez-Sierra D, et al. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. J Autoimmun. 2019;103:102285. https://doi.org/10.1016/j.jaut.2019.05.013.

Zhang S, Wang L, Li M, Zhang F, Zeng X. The PD-1/PD-L pathway in rheumatic diseases. J Formos Med Assoc. 2021;120(1 Pt 1):48–59. https://doi.org/10.1016/j.jfma.2020.04.004.

Article  CAS  PubMed  Google Scholar 

Álvarez-Sierra D, et al. Lymphocytic Thyroiditis Transcriptomic Profiles Support the Role of Checkpoint Pathways and B Cells in Pathogenesis. Thyroid. 2022;32(6):682–93. https://doi.org/10.1089/thy.2021.0694.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salazar-Viedma M, Vergaño-Salazar JG, Pastenes L, D’Afonseca V. Simulation Model for Hashimoto Autoimmune Thyroiditis Disease. Endocrinol (United States). 2021;162. https://doi.org/10.1210/endocr/bqab190.

McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23(1):14–24. https://doi.org/10.1089/thy.2012.0374.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franco JS, Amaya-Amaya J, Anaya JM. Thyroid disease and autoimmune diseases. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors. Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013 Jul 18. Chapter 30. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459466/.

Kaykhaein MA, et al. Association of CTLA4 (rs4553808) and PTPN22 (rs2476601) gene polymorphisms with Hashimoto’s thyroiditis disease: A case-control study and an In-silico analysis. Meta Gene. 2020;24:100693. https://doi.org/10.1016/j.mgene.2020.100693.

Aversa T, et al. Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: An overview. Ital J Pediatr. 2015;41(1):1–5. https://doi.org/10.1186/s13052-015-0146-2.

Article  CAS  Google Scholar 

Martínez-Hernández R, Marazuela M. MicroRNAs in autoimmune thyroid diseases and their role as biomarkers. Best Pract Res Clin Endocrinol Metab. 2023;37(2): 101741. https://doi.org/10.1016/j.beem.2023.101741.

Article  CAS  PubMed  Google Scholar 

Bernecker C, et al. MicroRNAs miR-146a1, miR-155-2, and miR-200a1 are regulated in autoimmune thyroid diseases. Thyroid. 2012;22(12):1294–5. https://doi.org/10.1089/thy.2012.0277.

Article  CAS  PubMed  Google Scholar 

Klicka K, Grzywa TM, Mielniczuk A, Klinke A, Włodarski PK. The role of miR-200 family in the regulation of hallmarks of cancer. Front Oncol. 2022;12: 965231. https://doi.org/10.3389/fonc.2022.965231.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thai T-H, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604–8. https://doi.org/10.1126/science.1141229.

Article  CAS  PubMed  Google Scholar 

Tanaka PP, et al. miR-155 exerts posttranscriptional control of autoimmune regulator (Aire) and tissue-restricted antigen genes in medullary thymic epithelial cells. BMC Genom. 2022;23(1):404. https://doi.org/10.1186/s12864-022-08631-4.

Martínez-Hernández R, et al. Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases. EBioMedicine. 2019;50:329–42. https://doi.org/10.1016/j.ebiom.2019.10.061.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-Mediated Metastasis: Communication from a Distance. Dev Cell. 2019;49(3):347–60. https://doi.org/10.1016/j.devcel.2019.04.011.

Article  CAS  PubMed  Google Scholar 

Mirzaei R, et al. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases. J Neuroimmunol. 2021;358: 577640. https://doi.org/10.1016/j.jneuroim.2021.577640.

Article  CAS  PubMed  Google Scholar 

Chaudhari P, Ghate V, Nampoothiri M, Lewis S. Multifunctional role of exosomes in viral diseases: From transmission to diagnosis and therapy. Cell Signal. 2022;94: 110325. https://doi.org/10.1016/j.cellsig.2022.110325.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145. https://doi.org/10.1038/s41392-020-00261-0.

Rodríguez-Muñoz A, et al. Circulating microvesicles regulate treg and Th17 differentiation in human autoimmune thyroid disorders. J Clin Endocrinol Metab. 2015;100(12):E1531–9. https://doi.org/10.1210/jc.2015-3146.

Article  PubMed  Google Scholar 

Rodríguez-Muñoz A, et al. Circulating Microvesicles Regulate Treg and Th17 Differentiation in Human Autoimmune Thyroid Disorders. J Clin Endocrinol Metab. 2015;100(12):E1531-9. https://doi.org/10.1210/jc.2015-3146.

Article  PubMed  Google Scholar 

Boi F, Lai ML, Marziani B, Minerba L, Faa G, Mariotti S. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol. 2005;153(5):637–42. https://doi.org/10.1530/eje.1.02020.

Article  CAS  PubMed